IKK ε aggravates inflammatory response via phosphorylation of ERK in rheumatoid arthritis.
CONCLUSIONS: IKKε plays an important role in promoting nociception and inflammatory response in CIA. Our research demonstrated that knockout of IKKε may serve as a new direction for clinical prevention and treatment of rheumatoid arthritis. IKKε inhibitor amlexanox may become a new drug for the treatment of rheumatoid arthritis.
PMID: 29687872 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Arthritis | Autoimmune Disease | Drugs & Pharmacology | Men | Rheumatoid Arthritis | Rheumatology | Study